Notwithstanding, when exposing melanoma cells tothe HSP90 inhibitor 17-AAG, we observed that bcl-2 overexpression counteracts bothHIF-1α protein degradation induced by 17-AAG, and the reduction ofinteraction between HIF-1α and HSP90 induced by the inhibitor. Here, BCL2 is linked to melanoma.